The signing of an agreement on the transfer of all its shares over the Euroclinic to Generali Hellas, Akkadia Holdings Limited announced today (22.7.2025).
The transaction is the culmination of a successful strategic journey in which the Euroclinic was developed, strengthened and reinstated as a leading force in the field of private health in Greece.
As noted in the same announcement, Akkadia Holdings, as a key shareholder of the Euroclinic since 2020, has supported its dynamic development in a period full of challenges for the health system, enhancing infrastructure, clinical adequacy and administrative autonomy. The administrative team, along with medical and nursing staff, worked consistently to achieve an ambitious transformation plan.
Collaboration with Generali Hellas is the next natural step for the Euroclinic, providing access to international know -how, resources and strategic support, while ensuring the continuation of the open model of the company in collaboration with all insurance bodies.
The completion of the transaction is under the heresy of the regulatory approvals.
The Euroclinic has 175 nursing beds, 12 beds in the Intensive Care Unit (ICU), 11 surgical rooms, collaboration with 450 permanent doctors and 1000 external partners, 619 permanent administrative and nursing staff, 24 -hour emergency staff and 24 -hour.
Panos Dimitriou, CEO of Generali Hellas, said: “The acquisition of the Euroclinic is a key strategic move that enhances the multi -level ecosystem of services we are developing. It is fully integrated into our vision for a modern, anthropocentric and sustainable insurance, in which prevention, quality of care and constant added value to the customer play a decisive role. Generali in Greece has in recent years followed a steady growth course, with high strategic investments and constant boosting its presence in the market, in a way that virtually differentiates it and brings it to the forefront of the insurance area. With this investment, we confirm our commitment to continue with the same reliability and seriousness to take steady steps and lead the transformation of the insurance landscape, aiming to provide high quality services while ensuring, at the same time, the optimum experience of people. ”
Nikolas Plakopotas, Vice President of the Board of Directors Euroclinic stated in this regard: “5 years ago most of the Global Finance fund investors who held the Euroclinic, joined forces with the Euroclinic management team and proceeded with an ambitious venture. Today, the Euroclinic, after being managed to grow, stabilize and reinstall as a health protagonist, closes this cycle successfully. The agreement with Generali is a natural continuation of this course and we believe that it will give further impetus to the group, maintaining its anthropocentric character and its commitment to all partners – doctors, insurance organizations and staff. A warm thank you to all those who trusted us, helped and supported to this day. “